CopyFind
Ersoryn 60 Injection
medicine 📍 IN

Ersoryn 60 Injection

638,00 ₹

Analogs of Ersoryn 60 Injection

Find cheaper analogs and generic equivalents for Ersoryn 60 Injection.

Ingredients

सक्रिय अवयव: Enoxaparin


उत्पाद अवलोकन

About Ersoryn 60 Injection

Ersoryn 60 Injection is a medication containing the active ingredient Enoxaparin, classified as Anticoagulant medication (blood thinner). Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication. It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Enoxaparin sodium injection is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT).
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Enoxaparin, the active ingredient in Ersoryn 60 Injection, belongs to the Anticoagulant medication (blood thinner) class. 1 INDICATIONS AND USAGE Enoxaparin sodium injection is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness ( 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Ersoryn 60 Injection. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Ersoryn 60 Injection for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Ersoryn 60 Injection.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.